Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00412438
Status:
UNKNOWN
Last Update Posted:
2006-12-18
First Post:
2006-12-15
Brief Title:
Investigation of Genetic Risk of Atrial Fibrillation
Sponsor:
Nagoya University
Organization:
Nagoya University
Study Overview
Official Title:
Investigation of Genetic Risk of Atrial Fibrillation
Status:
UNKNOWN
Status Verified Date:
2006-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The atrial fibrillation AF is the most common cardiac rhythm disturbance that is responsible for substantial morbidity and mortality independent of associated heart disease or other risk factors Even in the absence of preexisting cardiovascular disease AF remains significantly associated with excess mortality rates The current unsatisfactory treatment for AF comes from lack of understanding of the pathophysiology of AF The purpose of this study is to identify gene polymorphisms that confer susceptibility to atrial fibrillation Patients with AFN500 and healthy volunteerN1000 without AF are enrolled in this study Patients with coronary artery disease severe valvular heart disease cardiomyopathy or heart failure were excluded from the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None